Savara, Inc. (SVRA)
5.565
-0.02
(-0.45%)
USD |
NASDAQ |
Aug 24, 16:00
5.565
0.00 (0.00%)
After-Hours: 19:20
Savara 1 Year Total Returns (Daily) : 83.28% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 83.28% |
| August 20, 2026 | 77.67% |
| August 19, 2026 | 82.95% |
| August 18, 2026 | 76.07% |
| August 17, 2026 | 76.64% |
| August 14, 2026 | 78.74% |
| August 13, 2026 | 95.19% |
| August 12, 2026 | 120.9% |
| August 11, 2026 | 106.3% |
| August 10, 2026 | 117.0% |
| August 07, 2026 | 121.7% |
| August 06, 2026 | 111.3% |
| August 05, 2026 | 104.1% |
| August 04, 2026 | 110.5% |
| August 03, 2026 | 105.8% |
| July 31, 2026 | 110.8% |
| July 30, 2026 | 116.4% |
| July 29, 2026 | 101.5% |
| July 28, 2026 | 100.4% |
| July 27, 2026 | 110.5% |
| July 24, 2026 | 116.1% |
| July 23, 2026 | 130.9% |
| July 22, 2026 | 134.4% |
| July 21, 2026 | 155.0% |
| July 20, 2026 | 142.9% |
| Date | Value |
|---|---|
| July 17, 2026 | 135.9% |
| July 16, 2026 | 139.0% |
| July 15, 2026 | 153.7% |
| July 14, 2026 | 126.7% |
| July 13, 2026 | 140.2% |
| July 10, 2026 | 162.2% |
| July 09, 2026 | 165.4% |
| July 08, 2026 | 181.1% |
| July 07, 2026 | 165.4% |
| July 06, 2026 | 183.1% |
| July 02, 2026 | 196.2% |
| July 01, 2026 | 195.6% |
| June 30, 2026 | 170.2% |
| June 29, 2026 | 172.9% |
| June 26, 2026 | 167.0% |
| June 25, 2026 | 175.3% |
| June 24, 2026 | 155.7% |
| June 23, 2026 | 167.6% |
| June 22, 2026 | 176.2% |
| June 18, 2026 | 165.7% |
| June 17, 2026 | 163.7% |
| June 16, 2026 | 143.1% |
| June 15, 2026 | 141.2% |
| June 12, 2026 | 132.7% |
| June 11, 2026 | 139.5% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Gilead Sciences, Inc. | 29.10% |
| Insmed, Inc. | -5.15% |
| United Therapeutics Corp. | 65.17% |
| Vertex Pharmaceuticals, Inc. | 37.89% |
| SELLAS Life Sciences Group, Inc. | 778.4% |